1. Home
  2. AVBP vs NTGR Comparison

AVBP vs NTGR Comparison

Compare AVBP & NTGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVBP
  • NTGR
  • Stock Information
  • Founded
  • AVBP 2021
  • NTGR 1996
  • Country
  • AVBP United States
  • NTGR United States
  • Employees
  • AVBP N/A
  • NTGR N/A
  • Industry
  • AVBP
  • NTGR Telecommunications Equipment
  • Sector
  • AVBP
  • NTGR Utilities
  • Exchange
  • AVBP NYSE
  • NTGR Nasdaq
  • Market Cap
  • AVBP 617.4M
  • NTGR 713.6M
  • IPO Year
  • AVBP 2024
  • NTGR N/A
  • Fundamental
  • Price
  • AVBP $18.14
  • NTGR $22.11
  • Analyst Decision
  • AVBP Strong Buy
  • NTGR Buy
  • Analyst Count
  • AVBP 6
  • NTGR 2
  • Target Price
  • AVBP $39.00
  • NTGR $21.00
  • AVG Volume (30 Days)
  • AVBP 271.0K
  • NTGR 389.5K
  • Earning Date
  • AVBP 05-07-2025
  • NTGR 04-30-2025
  • Dividend Yield
  • AVBP N/A
  • NTGR N/A
  • EPS Growth
  • AVBP N/A
  • NTGR N/A
  • EPS
  • AVBP N/A
  • NTGR 0.42
  • Revenue
  • AVBP N/A
  • NTGR $673,759,000.00
  • Revenue This Year
  • AVBP $63.13
  • NTGR $3.06
  • Revenue Next Year
  • AVBP N/A
  • NTGR $4.86
  • P/E Ratio
  • AVBP N/A
  • NTGR $52.64
  • Revenue Growth
  • AVBP N/A
  • NTGR N/A
  • 52 Week Low
  • AVBP $14.35
  • NTGR $10.48
  • 52 Week High
  • AVBP $36.37
  • NTGR $31.55
  • Technical
  • Relative Strength Index (RSI)
  • AVBP 43.66
  • NTGR 43.46
  • Support Level
  • AVBP $15.55
  • NTGR $21.67
  • Resistance Level
  • AVBP $18.72
  • NTGR $23.31
  • Average True Range (ATR)
  • AVBP 1.19
  • NTGR 1.48
  • MACD
  • AVBP 0.34
  • NTGR 0.06
  • Stochastic Oscillator
  • AVBP 76.95
  • NTGR 47.39

About AVBP ARRIVENT BIOPHARMA INC

ArriVent BioPharma Inc is a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. It seeks to utilize the team's deep drug development experience to maximize the potential of the lead development candidate, furmonertinib, and advance a pipeline of novel therapeutics, such as next-generation antibody-drug conjugates, through approval and commercialization in patients suffering from cancer, with an initial focus on solid tumors.

About NTGR NETGEAR Inc.

Netgear Inc is a provider of networking solutions. The reportable segments of the company are connected home, and Small and Medium Businesses (SMB). The Connected Home segment focuses on consumers and consists of high-performance, dependable, and easy-to-use 4G/5G mobile, Wi-Fi internet networking solutions, and smart devices such as Orbi Voice smart speakers and Meural digital canvas; and NETGEAR specializes in providing networking solutions for businesses, including wireless LAN, Pro AV applications for audio and video over Ethernet, security, and remote management.

Share on Social Networks: